Fri, August 13, 2010
Thu, August 12, 2010
Wed, August 11, 2010
Tue, August 10, 2010
Mon, August 9, 2010
Fri, August 6, 2010
Thu, August 5, 2010
Wed, August 4, 2010
Tue, August 3, 2010
Mon, August 2, 2010
Fri, July 30, 2010
Thu, July 29, 2010
Wed, July 28, 2010
Tue, July 27, 2010
Mon, July 26, 2010

NeuroMetrix to Present at Canaccord Genuity 30th Annual Growth Conference


//health-fitness.news-articles.net/content/2010/ .. ccord-genuity-30th-annual-growth-conference.html
Published in Health and Fitness on Tuesday, August 3rd 2010 at 11:06 GMT by Market Wire   Print publication without navigation


WALTHAM, Mass.--([ BUSINESS WIRE ])--NeuroMetrix, Inc. (Nasdaq: NURO), a health care company transforming patient care through neurotechnology, today announced that Shai Gozani, CEO, will be presenting at the Canaccord Genuity 30th Annual Growth Conference at the InterContinental Hotel, Boston, MA on August 10, 2010

NeuroMetrix's presentation is scheduled for Tuesday, August 10, 2010 at 3:30 pm (EDT). A live audio webcast will be available on the investor relations section of our corporate website - [ www.neurometrix.com ]. This webcast will be archived after the live event.

About NeuroMetrix

NeuroMetrix is a science-based health care company transforming patient care through neurotechnology. We provide innovative products for preservation and restoration of nerve and spinal cord function, and pain control. To date, our focus has been primarily on the assessment of neuropathies. Neuropathies affect the peripheral nerves and parts of the spine and are frequently caused by or associated with carpal tunnel syndrome, diabetes, sciatica, and other clinical disorders. We market systems for the performance of nerve conduction studies and needle electromyography procedures. Our product pipeline includes a system designed to deliver pharmacologic agents such as anesthetics and corticosteroids in close proximity to nerves for regional anesthesia, pain control, and the treatment of focal neuropathies. We are also developing devices and pharmaceutical agents to treat peripheral nerve and spinal cord injuries. For more information, visit [ www.neurometrix.com ].


Publication Contributing Sources